Vibegron for BPH Patients with Persistent Overactive Bladder Symptoms

Buy Lab Tests Online

madman

Super Moderator

1733115197058.png



David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite alpha-blocker treatment. The study demonstrates significant improvements in various urinary symptoms, including micturitions, urgency episodes, and nocturia. Dr. Staskin highlights the drug's favorable safety profile, particularly noting the lack of increased urinary retention risk. The discussion explores the potential for using beta-3 agonists in different patient populations, including those with predominant OAB symptoms or post-operative cases. Drs. Crawford and Staskin emphasize the importance of this data for both urologists and primary care physicians in managing patients with persistent OAB symptoms. They also touch on the potential for expanding Vibegron's FDA-approved indications and the need to disseminate this information to family practice doctors who often treat these patients.

BPH treatment.png
 
Last edited by a moderator:
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

bodybuilder test discounted labs
cheap enclomiphene
TRT in UK Balance my hormones
Discounted Labs
Testosterone Doctor Near Me
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
BUY HCG CIALIS

Online statistics

Members online
5
Guests online
10
Total visitors
15

Latest posts

Top